Cellective Raises $5M Bridge To $25M Series B
By Azam on October 28, 2008 Add a Comment 
CELLective Dx develops cancer diagnostic to analyze cancer form CTC form patients’ blood through bio chip diagnostic tools and using the dynamics of micro fluidic technology. Cellective Dx takes advantage of rare circulating tumour cells in cancer patients by bio chip…
Continue Reading...